Results
Of the participants, 9% reported non-adherence on the MARS-5 (score
<24). Associations were found between non-adherence and both
reported side effects and side effect burden. Furthermore patients’
belief that DOACs have unpleasant side effects was associated with both
non-adherence and more side-effects. No associations were found between
adherence and either gender, indication, DOAC or dosage.